Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board

SOUTH SAN FRANCISCO, Calif., March 22, 2021 -- (Healthcare Sales & Marketing Network) -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering... Biopharmaceuticals, Oncology, Personnel Sutro Biopharma, XpressCF+, multiple myeloma, non-Hodgkin lymphoma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news